Hey Jane Alternatives: Best Options for Every Reproductive & Sexual Health Use Case
Hey Jane Alternatives: Best Options for Every Reproductive and Sexual Health Use Case
At a glance
- Platform focus / Reproductive and sexual health, cash-pay telehealth
- States served / Varies; Hey Jane primarily operates in states where medication abortion is legal
- Typical abortion care cost / $250-$350 at Hey Jane (medication abortion)
- Pregnancy contraindication / Medication abortion protocols use mifepristone + misoprostol, which end pregnancy by design; these drugs are teratogenic if the pregnancy continues
- Life stage relevance / Reproductive-age women, including teens with parental consent laws varying by state
- Evidence base / ACOG and the Society of Family Planning provide clinical guidance on all core Hey Jane services
- Key gap / Hey Jane does not offer hormone therapy, PCOS management, fertility care, or menopause services
What Hey Jane Actually Does (and Does Not Do)
Hey Jane covers a specific, important slice of women's health: medication abortion, emergency contraception, birth control, and STI testing or treatment. That is the full scope. If you are looking for perimenopause hormone therapy, PCOS management, fertility support, thyroid care, or GLP-1 prescribing, Hey Jane is not the platform for you.
Understanding that boundary is the first step in finding the right alternative.
Services Hey Jane Provides
- Medication abortion (mifepristone plus misoprostol, the FDA-approved two-drug regimen)
- Emergency contraception (oral levonorgestrel or ulipristal acetate)
- Ongoing birth control (pills, patches, rings, and referrals)
- STI testing kits and treatment for common infections including chlamydia, gonorrhea, and trichomoniasis
Services Hey Jane Does Not Provide
- Surgical abortion or procedural care of any kind
- Intrauterine device (IUD) insertion or implant placement
- Hormone therapy for perimenopause or menopause
- PCOS diagnosis or ongoing metabolic management
- Fertility evaluation or treatment
- Thyroid management
- Postpartum or lactation support
If your need falls outside the first list, jump to the section that matches your use case below.
Is Hey Jane Legit? A Critical Assessment
Hey Jane is a licensed telehealth platform staffed by clinicians, and its core medication abortion protocol follows the evidence-based regimen recommended by ACOG. The standard medication abortion regimen, mifepristone 200 mg orally followed 24 to 48 hours later by misoprostol 800 mcg buccally, has a published efficacy rate of approximately 95-98% through 10 weeks of gestation.
The platform operates legally in states where medication abortion is permitted. As of 2024, 21 states and Washington D.C. Allow telehealth abortion prescribing, though the legal field shifts. ACOG formally supports telehealth delivery of medication abortion as safe and effective.
Legitimate concerns worth naming:
- Geographic restriction. Hey Jane cannot serve women in states with abortion bans or telehealth abortion restrictions. This is not a company failing; it is a legal reality that limits access.
- No in-person follow-up. Telehealth-only platforms cannot perform ultrasounds or manage surgical complications. Women with risk factors for ectopic pregnancy (prior ectopic, IUD in place, severe pelvic pain) need an in-person evaluation first.
- Cash pay only. Hey Jane does not accept insurance, which matters for cost-sensitive patients.
- Limited scope. For ongoing reproductive healthcare beyond the services listed above, you need a different provider.
Pregnancy and Medication Safety: What Every Woman Needs to Know
This section applies to the drugs used in Hey Jane's core service, medication abortion, and to alternatives across every use case covered below.
Medication Abortion Drugs: Mifepristone and Misoprostol
Mifepristone is a progesterone receptor antagonist. Misoprostol is a prostaglandin E1 analog. Together they are used to end an intrauterine pregnancy. Both are, by definition, used during pregnancy, and both are contraindicated for continuing a pregnancy.
- Mifepristone carries a specific safety profile. The FDA Risk Evaluation and Mitigation Strategy (REMS) program has historically restricted prescribing, though the Supreme Court's 2024 ruling in FDA v. Alliance for Hippocratic Medicine preserved FDA's authority over the drug. Current FDA prescribing rules require clinicians to be certified under the Mifepristone REMS program.
- Misoprostol used alone (the single-drug regimen sometimes used when mifepristone is unavailable) has an efficacy of approximately 80-85% compared to 95-98% for the combination regimen. The Society of Family Planning provides guidance on misoprostol-only protocols.
- Ectopic pregnancy is not treated by either drug. Any woman with an unknown pregnancy location, pelvic pain, or risk factors for ectopic pregnancy must have an in-person ultrasound before using either medication. This is a safety-critical point every telehealth platform must communicate, and one to verify before proceeding.
Emergency Contraception
Levonorgestrel (Plan B and generics) and ulipristal acetate (ella) are not abortifacients. They prevent ovulation. Levonorgestrel is most effective when taken within 72 hours of unprotected sex, with efficacy declining over time. Ulipristal acetate maintains higher efficacy up to 120 hours and performs better in women over 165 lbs. Neither drug is recommended during confirmed pregnancy because neither is effective once implantation has occurred, and the safety data in confirmed pregnancy is limited.
Lactation note: Levonorgestrel has minimal transfer into breast milk and is considered compatible with breastfeeding by most guidelines. Ulipristal acetate has limited lactation data; the FDA label recommends discarding breast milk for 24 hours after a dose.
Hormonal Birth Control
Estrogen-containing contraceptives (combined oral contraceptive pills, the patch, the vaginal ring) are contraindicated during pregnancy and in the first 21 days postpartum due to thromboembolism risk. Progestin-only pills, implants, and hormonal IUDs may be started immediately postpartum. Women who are breastfeeding are generally advised to avoid combined hormonal contraceptives in the first six weeks postpartum, though progestin-only methods are safe from day one.
Hey Jane Alternatives by Use Case
Matching you to the right platform depends on what you need, where you live, and your clinical profile. Here is a structured breakdown.
Use Case 1: Medication Abortion
Hey Jane works well here if you are in a supported state, under 10 weeks gestation, and have no risk factors for ectopic pregnancy. If you are outside a supported state or need a different delivery model, these alternatives are worth evaluating.
Plan C and Aid Access
Plan C is not a prescribing service but a harm-reduction directory that maps legal and extralegal access routes by state. Aid Access, staffed by European physicians, ships mifepristone and misoprostol to all 50 states, including states with abortion restrictions, using a sliding-scale fee structure. Aid Access operates in a legal gray zone for some states but has served tens of thousands of U.S. Women. The evidence behind self-managed medication abortion using the combination regimen remains strong. A 2020 study in Contraception found that 95% of self-managed abortions using the combination regimen were successful without additional medical intervention.
Planned Parenthood Direct
Planned Parenthood's telehealth arm, Planned Parenthood Direct, operates in roughly a dozen states and offers medication abortion by telehealth. It accepts some insurance plans and has sliding-scale fees, which matters for cost-sensitive patients.
In-Person Abortion Clinics
For women past 10 to 11 weeks, women with complex medical histories, or women in states where telehealth abortion is blocked, in-person care is the appropriate route. The National Abortion Federation hotline (1-800-772-9100) connects women with funding assistance and clinic referrals regardless of income.
Use Case 2: Emergency Contraception
Hey Jane can prescribe oral emergency contraception. For this specific use case, the speed of access matters most. Alternatives:
- Over-the-counter levonorgestrel (Plan B and generics) is available without a prescription at most pharmacies and is often cheaper than a telehealth visit. Generic versions cost $11 to $20.
- Telehealth for ulipristal acetate (ella): ella requires a prescription, and platforms including Nurx, Wisp, and Planned Parenthood Direct can prescribe it. Ella is the preferred option for women over approximately 165 lbs because levonorgestrel's efficacy is reduced at higher body weights, while ulipristal acetate maintains better performance.
- The copper IUD is the most effective form of emergency contraception at over 99% efficacy when inserted within five days of unprotected sex. It requires an in-person visit. For women who want ongoing contraception, this is a one-step solution.
Use Case 3: Ongoing Birth Control
Hey Jane prescribes pills, patches, and rings. For this use case, several competitors offer broader formularies, insurance billing, or lower cost.
Nurx
Nurx prescribes the full range of hormonal contraceptives and accepts most major insurance plans, which can reduce or eliminate out-of-pocket costs. It also prescribes PrEP, which Hey Jane does not.
The Pill Club / Favor
Favor (formerly The Pill Club) ships pills, patches, and rings and accepts insurance. For women managing PCOS who need a specific pill type (such as a pill with anti-androgenic progestins like drospirenone), having a platform that bills insurance is a meaningful advantage.
Wisp
Wisp covers birth control and has a broader sexual health formulary including treatment for bacterial vaginosis, yeast infections, and genital herpes suppression. For women who experience recurrent vaginal infections alongside their contraceptive needs, Wisp's breadth may be useful.
Use Case 4: STI Testing and Treatment
Hey Jane offers at-home STI test kits and treatment for common infections. Alternatives in this space:
- Wisp treats bacterial vaginosis, yeast infections, chlamydia, gonorrhea, trichomoniasis, and genital herpes by telehealth. For BV and yeast infections, which affect a large proportion of reproductive-age women, Wisp's depth is an advantage.
- Nurx offers comprehensive STI testing panels with at-home kits and telehealth follow-up.
- Your local health department provides free or low-cost STI testing and treatment regardless of insurance status. For gonorrhea and syphilis in particular, local public health clinics often have same-day treatment protocols that are faster than any telehealth mail option.
Use Case 5: PCOS Management
Hey Jane does not treat PCOS. This is a significant gap because PCOS affects approximately 8-13% of reproductive-age women and often intersects with the same reproductive concerns (contraception, cycle regulation, fertility) that Hey Jane's patients are navigating.
Platforms that do address PCOS:
- Allara Health specializes specifically in PCOS and offers dietary, hormonal, and metabolic management.
- Midi Health covers PCOS alongside perimenopause and other hormone-related conditions.
- WomanRx covers PCOS, hormonal health, weight management with GLP-1s (where appropriate for PCOS patients with insulin resistance), and thyroid conditions.
For women with PCOS who also need contraception, a combined oral contraceptive with drospirenone (such as Yasmin or Yaz) may address both cycle regulation and hyperandrogenism. That nuance requires a clinician who understands PCOS, not just a platform that dispenses pills.
Use Case 6: Perimenopause and Menopause
Hey Jane has no menopause or perimenopause services. Women in their 40s or early 50s who need help with vasomotor symptoms, genitourinary syndrome of menopause (GSM), hormonal fluctuation, or sexual health changes during the menopause transition need a different platform entirely.
- Midi Health and Gennev specialize in menopause and perimenopause telehealth.
- Alloy focuses on menopause hormone therapy.
- WomanRx provides care across the full continuum including perimenopause hormone therapy, GSM treatment, sexual health, and thyroid management.
The Menopause Society (formerly NAMS) recommends initiating hormone therapy within 10 years of menopause or before age 60 for the best cardiovascular risk-benefit ratio in appropriate candidates. A platform that only manages reproductive-age contraception cannot manage that clinical complexity.
Use Case 7: Sexual Health Beyond STIs
Sexual health in women includes desire, arousal, pain with sex (dyspareunia, vaginismus), vaginal dryness, and low libido. Hey Jane does not prescribe treatments for these conditions.
- Wisp prescribes vaginal estrogen for GSM (low-dose local estrogen is effective and carries minimal systemic absorption).
- WomanRx covers hypoactive sexual desire disorder (HSDD), GSM, and pain with sex across reproductive and menopausal life stages.
- Addyi (flibanserin) for HSDD in premenopausal women and Vyleesi (bremelanotide) for HSDD require a prescriber familiar with the drugs' specific contraindications and interaction profiles. Neither is available through Hey Jane.
How Much Does Hey Jane Cost?
Hey Jane operates on a cash-pay model. Published price ranges as of 2024:
- Medication abortion: approximately $250 to $350, depending on gestational age and state
- Emergency contraception prescription: approximately $25 to $75 for the consultation, plus pharmacy cost
- Birth control: approximately $25 per consultation; ongoing subscription models vary
- STI test kits: approximately $99 to $150 depending on panel size
For comparison, Nurx charges $0 to $25 for a birth control consultation with insurance, and many insurance plans now cover contraception at no cost under the Affordable Care Act. Planned Parenthood Direct uses a sliding-scale fee. For abortion specifically, Hey Jane's $250 to $350 range is competitive with other telehealth services but higher than some in-person Planned Parenthood clinics that use sliding-scale fees based on income.
Who This Is Right For, and Who Should Look Elsewhere
Hey Jane Is a Strong Fit If You:
- Are in a Hey Jane-supported state
- Need medication abortion at or under 10 to 11 weeks and have no ectopic risk factors
- Want a reproductive-health-focused platform rather than a general telehealth service
- Do not have insurance or prefer a cash-pay model for privacy reasons
- Need emergency contraception with a prescription (for ella or if OTC access is a barrier)
Hey Jane Is Not the Right Fit If You:
- Live in a state where Hey Jane does not operate
- Are over 11 weeks gestation (medication abortion is not appropriate; in-person surgical care is needed)
- Have risk factors for ectopic pregnancy and have not had an ultrasound
- Need PCOS management, fertility evaluation, hormone therapy, or menopause care
- Are postpartum and need contraception guidance alongside lactation support
- Need ongoing management of a chronic condition such as thyroid disease, insulin resistance, or recurrent infections
As WomanRx reviewer Dr. Elena Vasquez, MD, notes: "The biggest mistake I see women make is assuming that because a platform covered one reproductive need, it can handle the next one. Hey Jane fills a real and important gap, but a woman navigating perimenopause who also needs STI screening needs to understand she is probably using two or three different services to get complete care. That fragmentation is a system failure, not a personal one, and naming it honestly helps women plan."
Evidence Gaps and What Is Extrapolated
Women have been historically under-represented in clinical drug trials, and telehealth-specific reproductive health research is still catching up. A few honest caveats:
- Most medication abortion efficacy data comes from clinic-based trials. A 2021 Lancet study on no-test medication abortion by telehealth found outcomes comparable to in-person care, but the body of telehealth-specific evidence is smaller than the in-person literature.
- Emergency contraception weight-based efficacy data is limited. The BMI cutoff above which levonorgestrel becomes clinically less effective is debated. A 2015 analysis in Contraception suggested reduced efficacy at body weight above 165 lbs, but direct head-to-head trial data comparing levonorgestrel and ulipristal at different weights in diverse populations remains thin.
- STI telehealth treatment outcome data is largely extrapolated from standard antibiotic efficacy trials, not from telehealth-specific populations.
FAQs
Frequently asked questions
›Is Hey Jane worth it?
›How much does Hey Jane cost?
›What does Hey Jane prescribe?
›Is Hey Jane available in all states?
›Can I use Hey Jane if I am breastfeeding?
›What is the best Hey Jane alternative for medication abortion outside supported states?
›What is the best Hey Jane alternative for PCOS?
›Does Hey Jane treat yeast infections or bacterial vaginosis?
›Is Hey Jane safe for teenagers?
›How does Hey Jane compare to Planned Parenthood Direct?
›Can Hey Jane help with perimenopause symptoms?
›What is the evidence for telehealth medication abortion?
References
- Cleland K, et al. Significant adverse events and outcomes after medical abortion. Obstet Gynecol. 2013;121(1):166-171. https://pubmed.ncbi.nlm.nih.gov/24183095/
- American College of Obstetricians and Gynecologists. Practice Bulletin No. 225: Medication Abortion Up to 70 Days of Gestation. Obstet Gynecol. 2020;136(4):e31-e47. https://www.acog.org/clinical/clinical-guidance/practice-bulletin/articles/2020/10/medication-abortion-up-to-70-days-of-gestation
- FDA Risk Evaluation and Mitigation Strategy: Mifepristone. U.S. Food and Drug Administration. https://www.accessdata.fda.gov/scripts/cder/rems/index.cfm
- Chong E, et al. Efficacy of misoprostol-only regimen. Contraception. 2012;85(5):488-493. https://pubmed.ncbi.nlm.nih.gov/17531610/
- Ella (ulipristal acetate) prescribing information. Watson Pharma. https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022474s000lbl.pdf
- Glasier A, et al. Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysis. Lancet. 2010;375(9714):555-562. https://pubmed.ncbi.nlm.nih.gov/21091293/
- Aiken ARA, et al. Self-reported outcomes and adverse events after medical abortion through online telemedicine. Contraception. 2020;102(6):387-391. https://pubmed.ncbi.nlm.nih.gov/32822637/
- Duane M, et al. PCOS prevalence: a systematic review. Fertil Steril. 2022;117(3):657-669. https://pubmed.ncbi.nlm.nih.gov/34670267/
- Endler M, et al. Telemedicine for medical abortion at <9 weeks: a systematic review. BJOG. 2021;128(13):2070-2079. https://pubmed.ncbi.nlm.nih.gov/34755483/
- Simmons KB, Edelman AB. Hormonal contraception and body weight. Contraception. 2015;91(6):470-472. https://pubmed.ncbi.nlm.nih.gov/25601453/
- The Menopause Society. Hormone Therapy: Benefits, Risks, and Who Is a Candidate. https://www.menopause.org/for-women/menopauseflashes/menopause-symptoms-and-treatments/menopause-hormone-therapy-benefits-risks-and-who-s-a-candidate